BRIEF-New Data From Vaxart Oral Covid-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity Against Other Coronaviruses

Reuters2021-05-04

May 3 (Reuters) - Vaxart Inc :

* NEW DATA FROM VAXART ORAL COVID-19 VACCINE PHASE I STUDY SUGGESTS BROAD CROSS-REACTIVITY AGAINST OTHER CORONAVIRUSES

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • robinlee64
    2021-05-04
    robinlee64
    Let's see how market react to this news tonight!!
  • S土豪熊貓G
    2021-05-04
    S土豪熊貓G
    Finally heading for approval soon. Buy buy buy! 
  • Six six six
    2021-05-04
    Six six six
    Soaring soon
    • S土豪熊貓G: 
      Myes, a small dip last night and it sore aGain. as prediCted. it will sore high. eadliy $13 resisTance. buy buy buy
Leave a comment
3